Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
1999 3
2000 1
2001 1
2002 6
2003 4
2004 7
2005 7
2006 6
2007 8
2008 3
2009 2
2010 2
2011 1
2012 3
2013 7
2014 6
2015 4
2016 3
2017 4
2018 4
2019 9
2020 7
2021 10
2022 9
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Results by year

Filters applied: . Clear all
Page 1
A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology.
Lazar V, Zhang B, Magidi S, Le Tourneau C, Raymond E, Ducreux M, Bresson C, Raynaud J, Wunder F, Onn A, Felip E, Tabernero J, Batist G, Kurzrock R, Rubin E, Schilsky RL. Lazar V, et al. Among authors: onn a. Ther Adv Med Oncol. 2023 Mar 31;15:17588359231156382. doi: 10.1177/17588359231156382. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 37025260 Free PMC article.
Driver mutation characteristics of phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) in advanced non-small cell lung cancer.
Daher S, Zer A, Tschernichovsky R, Yacobi R, Barshack I, Tsabari S, Rottenberg Y, Zick A, Gottfried T, Lobachov A, Marom EM, Urban D, Saad A, Gantz-Sorotsky H, Onn A, Bar J. Daher S, et al. Among authors: onn a. Lung Cancer. 2023 Apr;178:229-236. doi: 10.1016/j.lungcan.2023.02.023. Epub 2023 Mar 2. Lung Cancer. 2023. PMID: 36898331 Free article.
ALK Inhibitors or Chemotherapy for Third Line in ALK-positive NSCLC? Real-world Data.
Moskovitz M, Dudnik E, Shamai S, Rotenberg Y, Popovich-Hadari N, Wollner M, Zer A, Gottfried M, Mishaeli M, Rosenberg SK, Onn A, Merimsky O, Urban D, Peled N, Maimon N, Bar J. Moskovitz M, et al. Among authors: onn a. Oncologist. 2022 Feb 3;27(1):e76-e84. doi: 10.1093/oncolo/oyab005. Oncologist. 2022. PMID: 35305096 Free PMC article.
Familial cholinergic urticaria.
Onn A, Levo Y, Kivity S. Onn A, et al. J Allergy Clin Immunol. 1996 Oct;98(4):847-9. doi: 10.1016/s0091-6749(96)70137-9. J Allergy Clin Immunol. 1996. PMID: 8876564 No abstract available.
Long term follow-up of EGFR mutated NSCLC cases.
Rennert G, Gottfried M, Rennert HS, Lejbkowicz F, Frank M, Cohen I, Kelt S, Agbarya A, Dudnik E, Dudnik J, Katznelson R, Mishali M, Maimon Rabinovich N, Nechushtan H, Onn A, Keren Rosenberg S, Wollner M, Zer A, Bar J, Gronich N. Rennert G, et al. Among authors: onn a. Transl Oncol. 2021 Jan;14(1):100934. doi: 10.1016/j.tranon.2020.100934. Epub 2020 Nov 10. Transl Oncol. 2021. PMID: 33186889 Free PMC article.
121 results